Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
Sitala seals $670M deal for Fosun immune disease drug
Right on the heels of a similar deal, Fosun Pharma has outlicensed a second inflammatory disease candidate to a Western biotech startup.
Angus Liu
Aug 26, 2025 2:44pm
Lineage tunes up hearing loss transplant with $12M research pact
Aug 26, 2025 11:00am
Novartis pens BioArctic neuro pact worth $30M upfront
Aug 26, 2025 8:30am
AbbVie inks $1.2B deal to buy Gilgamesh's psychedelic program
Aug 25, 2025 9:42am
Kite sails into in vivo CAR-T space via $350M Interius buyout
Aug 21, 2025 9:59am
After 'complete standstill,' biotech market reaches new normal
Aug 20, 2025 11:04am
